These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1785 related articles for article (PubMed ID: 19659516)
1. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis. Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC; Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516 [TBL] [Abstract][Full Text] [Related]
2. Tuberculosis chemotherapy and sputum conversion among HIV-seropositive and HIV-seronegative patients in south-eastern Uganda. Bwire R; Borgdorff MW; Sticht-Groh V; Rieder HL; Kawuma HJ; Bretzel G; Rüsch-Gerdes S East Afr Med J; 1999 Jun; 76(6):307-13. PubMed ID: 10750516 [TBL] [Abstract][Full Text] [Related]
3. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months. Nolan CM; Goldberg SV Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140 [TBL] [Abstract][Full Text] [Related]
4. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [TBL] [Abstract][Full Text] [Related]
5. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy. Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696 [TBL] [Abstract][Full Text] [Related]
6. Yield of continued monthly sputum evaluation among tuberculosis patients after culture conversion. Sundaram V; Fujiwara PI; Driver CR; Osahan SS; Munsiff SS Int J Tuberc Lung Dis; 2002 Mar; 6(3):238-45. PubMed ID: 11934142 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment. Harries AD; Gausi F; Chimzizi R; Salaniponi FM Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479 [TBL] [Abstract][Full Text] [Related]
8. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion]. Nowak D; Radenbach D; Magnussen H Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634 [TBL] [Abstract][Full Text] [Related]
9. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis. Park SK; Kim JH; Kang H; Cho JS; Smego RA Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342 [TBL] [Abstract][Full Text] [Related]
11. A controlled clinical trial of oral short-course regimens in the treatment of sputum-positive pulmonary tuberculosis. Tuberculosis Research Centre. Int J Tuberc Lung Dis; 1997 Dec; 1(6):509-17. PubMed ID: 9487448 [TBL] [Abstract][Full Text] [Related]
12. Modified short-course chemotherapy of pulmonary tuberculosis in Ibadan, Nigeria--a preliminary report. Ige OM; Bakare NA; Onadeko BO Afr J Med Med Sci; 2000 Mar; 29(1):51-3. PubMed ID: 11379469 [TBL] [Abstract][Full Text] [Related]
13. Should we take a history of prior treatment, and check sputum status at 2-3 months when treating patients for tuberculosis? Wilkinson D; Bechan S; Connolly C; Standing E; Short GM Int J Tuberc Lung Dis; 1998 Jan; 2(1):52-5. PubMed ID: 9562111 [TBL] [Abstract][Full Text] [Related]
14. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study. Tiwari S; Kumar A; Kapoor SK Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis. Tabarsi P; Baghaei P; Hemmati N; Mirsaeidi M; Kazempour M; Mansouri D; Masjedi MR East Mediterr Health J; 2009; 15(6):1346-50. PubMed ID: 20218123 [TBL] [Abstract][Full Text] [Related]
16. [Six-month short course chemotherapy containing pyrazinamide for initial treatment of pulmonary tuberculosis]. Wada M; Yosiyama T; Yosikawa M; Ogata H; Sugie T; Nakasono T; Sugita H Kekkaku; 1994 Nov; 69(11):671-80. PubMed ID: 7837720 [TBL] [Abstract][Full Text] [Related]
17. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach. Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R; Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298 [TBL] [Abstract][Full Text] [Related]
18. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment]. Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263 [TBL] [Abstract][Full Text] [Related]
19. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis. Güler M; Unsal E; Dursun B; Aydln O; Capan N Int J Clin Pract; 2007 Feb; 61(2):231-5. PubMed ID: 17166185 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions. Banu Rekha VV; Rajaram K; Kripasankar AS; Parthasarathy R; Umapathy KC; Sheikh I; Selvakumar N; Victor M; Niruparani C; Sridhar R; Jawahar MS Natl Med J India; 2012; 25(4):196-200. PubMed ID: 23278775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]